France· FR:63185466
CARTEOL L.P. 2 %, collyre à libération prolongée
A medicinal product containing chlorhydrate de cartéolol, registered in France by LABORATOIRE CHAUVIN, on the national reimbursement list.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- CHLORHYDRATE DE CARTÉOLOL
- Manufacturer
- LABORATOIRE CHAUVIN
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- Yes
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- cip1334009357895251 flacon(s) compte-gouttes polyéthylène de 3 mlEUR 5.67
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Chlorhydrate de cartéolol in 11 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomCarteolol 1% eye dropsDowelhurst Ltd
- Japanカルテオロール塩酸塩ロートニッテンファーマ
- BelgiumArteoptic LA 1 %Bausch & Lomb Pharma
- ItalyCARTEABAK*collirio 5 ml 1%LABORATOIRES THEA
- SpainARTEOPTIC 1% COLIRIO DE LIBERACION PROLONGADABausch + Lomb Ireland Limited
- PolandCarteol LP 2%Medezin Sp. z o.o.
- SwitzerlandArteoptic LA
- NetherlandsArteoptic zonder conserveermiddel 20 mg/ml, oogdruppels, oplossing met verlengde afgifteBausch + Lomb Ireland Limited
Authorised across Europe · EMA
The same active substance is authorised in 11 EEA countries. Names it is sold under:
- Belgium · Arteoptic La, Arteoptic La Sine Conservans
- Czechia · Carteol Lp, Carteol Neo
- Spain · Arteoptic, Arteoptic Pf
- Croatia · Cartelomb
- Italy · Carteabak, Carteol
- Luxembourg · Arteoptic La, Arteoptic La Sine Conservans
- Netherlands · Arteoptic Zonder Conserveermiddel, Carteabak
- Poland · Carteol Lp, Carteol Lp Preservative Free
- Portugal · Physioglau, Physioglau Pf
- Slovenia · Cartelomb
- Slovakia · Carteol Lp, Carteol Neo
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ab92fee3-5cc2-4cca-a0fd-8a40f03de8ca GET /v1/drugs/ab92fee3-5cc2-4cca-a0fd-8a40f03de8ca?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "63185466",
"date_amm": "2002-03-25",
"type_amm": "Procédure de reconnaissance mutuelle",
"numero_ue": null,
"substance": "CHLORHYDRATE DE CARTÉOLOL",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "collyre à libération prolongée",
"voies_administration": "ophtalmique",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about chlorhydrate de cartéolol.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.